Cargando…

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy

BACKGROUND: Phagocytosis of apoptotic cells by macrophages induces a suppressor phenotype. Previous data from our group suggested that this occurs via Platelet-activating factor receptor (PAF-R)-mediated pathways. In the present study, we investigated the impact of apoptotic cell inoculation or indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Soraya I, Andrade, Luciana NS, Onuchic, Ana C, Nonogaki, Sueli, Fernandes, Patrícia D, Pinheiro, Mônica C, Rohde, Ciro BS, Chammas, Roger, Jancar, Sonia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881890/ https://www.ncbi.nlm.nih.gov/pubmed/20465821 http://dx.doi.org/10.1186/1471-2407-10-200

Ejemplares similares

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy
por: da Silva-Jr, I A, et al.
Publicado: (2017)

Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2018)

Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2017)

Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma
por: Onuchic, Ana Claudia, et al.
Publicado: (2012)

Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour
por: Hanks, Sandra, et al.
Publicado: (2014)

Endocrine Tumours
por: Reed, NS
Publicado: (1995)

Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor
por: Bachi, André Luis Lacerda, et al.
Publicado: (2012)

Is platelet activating factor (PAF) an important mediator in bronchial asthma?
por: Gundel, R. H., et al.
Publicado: (1992)

Interaction between PAF and human platelet membranes: a fluorescence study
por: Kantar, Ahmad, et al.
Publicado: (1992)

Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications
por: Muñoz-Cano, Rosa M., et al.
Publicado: (2019)

Interaction of platelets and tumour cells
por: Schor, A.
Publicado: (1983)

Engineering platelets for tumour targeting
por: Marriott, Gerard
Publicado: (2016)

Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion
Publicado: (1976)

Amide Derivatives of Ginkgolide B and Their Inhibitory Effects on PAF-Induced Platelet Aggregation
por: Shang, Qiang, et al.
Publicado: (2021)

Germ cell tumour chemotherapy.
por: Horwich, A.
Publicado: (1989)

Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration
por: Teixeira-da-Cunha, Mariana G. A., et al.
Publicado: (2013)

Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients
por: Harishkumar, Rajendran, et al.
Publicado: (2022)

Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene
por: Stafforini, Diana M.
Publicado: (2009)

Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism
por: Nasopoulou, Constantina, et al.
Publicado: (2011)

Leyes PAF fiscal, 2008.
Publicado: (2008)

Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
por: Li, Hongjun, et al.
Publicado: (2021)

Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor
por: Waller, Amie K., et al.
Publicado: (2013)

Enhancement of chemotherapy by manipulation of tumour pH
por: Raghunand, N, et al.
Publicado: (1999)

PAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats
por: Denizot, Y., et al.
Publicado: (1994)

The Growth of Human Tumours in Immunosuppressed Mice and Their Response to Chemotherapy
por: Berenbaum, M. C., et al.
Publicado: (1974)

Impact of tumour burden on chemotherapy-induced nausea and vomiting.
por: Hursti, T. J., et al.
Publicado: (1996)

Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.
por: Evans, T W, et al.
Publicado: (1990)

Chemotherapy for unresectable and recurrent intramedullary glial tumours in children
por: Doireau, V, et al.
Publicado: (1999)

Paf1 and Ctr9 subcomplex formation is essential for Paf1 complex assembly and functional regulation
por: Xie, Ying, et al.
Publicado: (2018)

PAF49: An RNA Polymerase I subunit essential for rDNA transcription and stabilization of PAF53
por: McNamar, Rachel, et al.
Publicado: (2023)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
por: Turner, N C, et al.
Publicado: (2010)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR
por: Deng, Meng, et al.
Publicado: (2019)

Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response
Publicado: (1976)

Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent
por: Patterson, L H, et al.
Publicado: (2000)

Chemotherapy promotes tumour cell hybridization in vivo
por: Yan, Bingyu, et al.
Publicado: (2015)

Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
por: Radulescu, Liliana Maria, et al.
Publicado: (2021)

Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer
por: Souza, Juliana L., et al.
Publicado: (2020)

Increased susceptibility to bladder inflammation in smokers: targeting the PAF–PAF receptor interaction to manage inflammatory cell recruitment
por: Marentette, John, et al.
Publicado: (2015)

PAF‐induced inflammatory and immuno‐allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects
por: Sharif, Najam A.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usb5ouui4ao41vfg5o53f47nn2